Logo image of SQD.CA

SQI DIAGNOSTICS INC (SQD.CA) Stock Fundamental Analysis

TSX-V:SQD - TSX Venture Exchange - CA78466B1085 - Common Stock - Currency: CAD

0.015  0 (0%)

Fundamental Rating

1

Taking everything into account, SQD scores 1 out of 10 in our fundamental rating. SQD was compared to 15 industry peers in the Health Care Equipment & Supplies industry. SQD has a bad profitability rating. Also its financial health evaluation is rather negative. SQD is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

SQD had negative earnings in the past year.
In the past year SQD has reported a negative cash flow from operations.
SQD had negative earnings in each of the past 5 years.
In the past 5 years SQD always reported negative operating cash flow.
SQD.CA Yearly Net Income VS EBIT VS OCF VS FCFSQD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 -5M -10M -15M

1.2 Ratios

The profitability ratios for SQD are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SQD.CA Yearly ROA, ROE, ROICSQD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 -200 -400 -600

1.3 Margins

SQD has a Gross Margin of 37.46%. This is in the lower half of the industry: SQD underperforms 62.50% of its industry peers.
In the last couple of years the Gross Margin of SQD has declined.
The Profit Margin and Operating Margin are not available for SQD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.35%
GM growth 5Y-13.93%
SQD.CA Yearly Profit, Operating, Gross MarginsSQD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 -500 -1K

More info and screens

0

2. Health

2.1 Basic Checks

SQD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SQD has more shares outstanding
SQD has a worse debt/assets ratio than last year.
SQD.CA Yearly Shares OutstandingSQD.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M
SQD.CA Yearly Total Debt VS Total AssetsSQD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M

2.2 Solvency

SQD has an Altman-Z score of -28.41. This is a bad value and indicates that SQD is not financially healthy and even has some risk of bankruptcy.
SQD has a worse Altman-Z score (-28.41) than 68.75% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -28.41
ROIC/WACCN/A
WACC10.48%
SQD.CA Yearly LT Debt VS Equity VS FCFSQD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 5M -5M -10M

2.3 Liquidity

SQD has a Current Ratio of 0.17. This is a bad value and indicates that SQD is not financially healthy enough and could expect problems in meeting its short term obligations.
SQD has a Current ratio of 0.17. This is amonst the worse of the industry: SQD underperforms 81.25% of its industry peers.
A Quick Ratio of 0.09 indicates that SQD may have some problems paying its short term obligations.
SQD's Quick ratio of 0.09 is on the low side compared to the rest of the industry. SQD is outperformed by 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.17
Quick Ratio 0.09
SQD.CA Yearly Current Assets VS Current LiabilitesSQD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M 8M 10M

More info and screens

3

3. Growth

3.1 Past

SQD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.39%.
Looking at the last year, SQD shows a very strong growth in Revenue. The Revenue has grown by 760.04%.
Measured over the past years, SQD shows a very strong growth in Revenue. The Revenue has been growing by 52.95% on average per year.
EPS 1Y (TTM)-16.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.73%
Revenue 1Y (TTM)760.04%
Revenue growth 3Y62.42%
Revenue growth 5Y52.95%
Sales Q2Q%494.92%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SQD.CA Yearly Revenue VS EstimatesSQD.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M 8M
SQD.CA Yearly EPS VS EstimatesSQD.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 -0.02 -0.04 -0.06 -0.08 -0.1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SQD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SQD.CA Price Earnings VS Forward Price EarningsSQD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SQD.CA Per share dataSQD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 -0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SQD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SQI DIAGNOSTICS INC

TSX-V:SQD (6/14/2023, 7:00:00 PM)

0.015

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)01-26 2022-01-26
Inst Owners0.99%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.11M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.73
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.02
BVpS-0.03
TBVpS-0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.46%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.35%
GM growth 5Y-13.93%
F-Score2
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 27.61%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.17
Quick Ratio 0.09
Altman-Z -28.41
F-Score2
WACC10.48%
ROIC/WACCN/A
Cap/Depr(3y)91.83%
Cap/Depr(5y)76.01%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.73%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)760.04%
Revenue growth 3Y62.42%
Revenue growth 5Y52.95%
Sales Q2Q%494.92%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-37.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-24.93%
OCF growth 3YN/A
OCF growth 5YN/A